Menorrhagia (excessive menstrual bleeding) is a common clinical problem of unknown aetiology. The freeradical and vasodilator nitric oxide (NO) relaxes the myometrial smooth muscle and is a strong candidate for the cause of excessive blood loss in menorrhagic patients. The aim of this study was to measure NO production in women with and without menorrhagia to detect nitric oxide synthase (NOS) isoforms in uterine cells and to investigate any steroid effects on myometrial NOS expression. We showed for the first time that menorrhagic endometrium produces significantly higher amounts of NOx (the sum of NO 2 -and NO 3 -) than control endometrium (P < 0.01). Inducible NOS (iNOS) protein was detected by immunoblotting in endometrial and myometrial tissue extracts. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) experiments revealed an induction of myometrial smooth muscle endothelial NOS (eNOS) expression by progesterone and 17β-oestradiol, while myometrial iNOS expression was unaffected by steroid hormones. These results are consistent with the hypothesis that NO plays a role in excessive menstrual bleeding and provide the first evidence on steroid regulation of eNOS in the human non-pregnant uterus.
Introduction
I) was first identified in neuronal tissues and is expressed constitutively, like eNOS (NOS III) which was first identified Menorrhagia, defined as excessive menstrual blood loss as a constitutive enzyme in vascular endothelial cells. iNOS (Hallberg et al., 1966) , remains a challenge at the therapeutic (NOS II), first described in macrophages, can be induced by and research level. In the UK, 31% of reproductive age women cytokines or bacterial lipopolysaccharides (LPS) (Fosterman suffer from menorrhagia and 80-90% of these women receive et al., 1991) . NO action has been associated with platelet unnecessary and ineffective treatment (Rees, 1991) . More than aggregation, relaxation of smooth muscles in the gastro-80% of menorrhagic women do not have an organic disease, intestinal and respiratory tract, neurotransmission and such as uterine tumours (polyps, fibroids, carcinomas), immunoactivation. Such regulatory functions of NO are infection or pregnancy. mediated via cyclic guanosine monophosphate (cGMP) Recent work has shown that blood clotting disorders were (Moncada et al., 1991) . responsible for a proportion of menorrhagia cases, but not for NO production has been assayed in the pregnant rat uterus, the majority of them (Kadir et al., 1998) . Much attention has by measuring its oxidation products nitrite (NO 2 -) and nitrate been focused on the uterus itself, and it seems that locally (NO 3 -), and an L-arginine-NO-cGMP pathway was found to derived factors and vascular changes control the amount of exist throughout pregnancy ; blood loss during menstruation. The correlation between uterine Jaing et al., 1996) . In the rat artery pulsatility index and amount of menstrual blood loss, and human myometrium, an L-arginine-NO system has an suggests that vascular factors may be involved in the pathoimportant role in inhibiting uterine contractility and possibly, genesis of menorrhagia (Hurskainen et al., 1999) . Previous maintaining pregnancy . However, NOS studies have also shown increased concentrations of prostaexpression decreases at term, when myometrial contractions glandins F 2α and E 2 in menstrual fluid of women with lead to labour (Weiner et al., 1994b; Buhimschi et al., 1996; menorrhagia (Rees et al., 1984b) , and increased prostaglandin Dong et al., 1996; Bansal et al., 1997; Riemer et al., 1997 ; E 2 receptors in myometrium, correlated with menstrual blood Norman et al., 1999) . Various studies have suggested a role loss (Cameron et al., 1988) .
of NO in regulation of menstrual blood loss (Norman, 1996 ; The free radical gas nitric oxide (NO) is produced after Norman and Cameron, 1996; Telfer et al., 1997) , and more catalytic oxidation of L-arginine by the enzyme nitric oxide recent work showed that NOS activity is increased during synthase (NOS). NOS occurs in three distinct isoforms: two menstruation, suggesting a role of NO in menstrual blood constitutive, Ca 2ϩ -dependent, isoforms endothelial NOS release and in endometrial apoptosis (Tschugguel et al., 1999) . (eNOS) and neuronal NOS (nNOS), and the Ca 2ϩ -independent As well as affecting vasodilation by relaxing the vascular smooth muscle, uterine-derived NO appears to act as a inducible NOS (iNOS) (Moncada et al., 1991) . nNOS (NOS All women recruited to the study were pre-menopausal, with suppressor of smooth muscle contractility, by maintaining normal menstrual cycles (25-35 days), had not been exposed to uterine quiescence during pregnancy and relaxing the nonsteroid treatment for three months prior to operation, did not have pregnant human myometrium (Cameron and Campbell, 1998) .
either an intrauterine contraceptive device (IUD) in situ or Ca 2ϩ -dependent isoforms eNOS and nNOS were previously evidence of uterine pathology, such as fibroids or polyps. Myometrial detected in human pregnant and non-pregnant endometrium biopsies were taken from the upper third of the uterine body and myometrium, while iNOS was detected in the pregnant~5 mm away from endometrial or serosal surfaces, immediately after and non-pregnant endometrium and pregnant myometrium hysterectomy. Endometrial biopsies were obtained by sharp dissection Telfer et al., 1997; Norman et al., 1999) . of uterine tissue. Myometrial samples were either snap-frozen in
In view of the suggested roles of NO in pregnancy and liquid nitrogen and stored at -70°C until use, or were collected in menstruation, it is of interest to study eNOS and iNOS ice-cold Hanks' balanced salt solution (HBSS, Sigma, Poole, UK) containing penicillin G (10 000 IU/ml) (Sigma) and streptomycin expression. eNOS is a known vasodilator of myometrial (7610 IU/ml) (Sigma), for enzymatic dispersion and cell culture. For vasculature and neighbouring smooth muscle cells (Tschugguel the control group, endometrial biopsies were obtained from either the et al., 1997) and iNOS was reported to have a steroid-mediated fundus, or the upper third of the uterine body, using a Sharman's action in the pregnant rat uterus (Ali et al., 1997) . human non-pregnant uterus is still unclear. Ca 2ϩ -dependent NOS isoforms were reported to be induced by oestrogens in
NOx assays
pregnant guinea pigs (Weiner et al., 1994a) and in non-pregnant Endometrial biopsies were collected from controls (n ϭ 18) and sheep (Figueroa and Massmann, 1995) . A progesterone-, from menorrhagic patients (n ϭ 20). The chronological dating but not 17β-oestradiol-mediated regulation of vascular adapta-(based on the last menstrual period) of the biopsies is shown on tions by NO was reported during pregnancy in rats (Buhimschi , 1995) . Progesterone was also suggested to be the steroid genized by an Ystral homogenizer (7801, Dottingen, setting 6) at hormone with the major steroid action on vascular tension 0°C in 20 mmol/l Tris-HCl (pH 7.4), 1 mmol/l EDTA, 50 mmol/l NaCl (BDH, Poole, UK), 2 µg/ml aprotinin (Sigma), 1% phenylduring pregnancy (Liao et al., 1996) . methylsulphonyl fluoride (PMSF; BDH). Two sequential centrifugaInducible NOS was found to play a role in initiation of tions were carried out at 13 000 rpm for 5 min at 4°C, in order to labour and cervical ripening in rats and progesterone was separate the cytosolic fraction (supernatant) from the membranous found to differentially regulate iNOS in the rat cervix and fraction (pellet). The latter was discarded.
uterus (Ali et al., 1997) . Recently, a synergistic role of NO For NOx determination, a manual spectrophotometric version and progesterone during the establishment of pregnancy in the of the Griess reaction was carried out according to previously rat was demonstrated (Chwalisz et al., 1999) . However, other published protocols (Tracey, 1992) . Samples were incubated at 37°C workers (Telfer et al., 1997) The aetiology of menorrhagia, however, remains largely (LDH) (10 IU/ml) (Roche Boehringer Manheim) and sodium pyruvate unknown. We introduce the hypothesis that uterine cells (10 mmol/l) (BDH).
(endometrial and/or myometrial) of women suffering from
The samples were then cooled at 4°C for 10 min and diazotization menorrhagia demonstrate an increased activity of NOS, a was performed by adding sulphanilamide (p-aminobenzene-sulphonconsequence of which is overproduction of NO, leading to amide; Sigma) at a final concentration of 1 mmol/l in 0.1 N HCl. dilatation, congestion of uterine vessels and excessive amount Centrifugation followed at 4000 rpm for 15 min, and 150 µl of each of menstrual blood loss. In addition to the main hypothesis of the supernatants were transferred to a corresponding well of a we have also assessed the role of sex steroids in regulating 96-well enzyme-linked immunosorbent assay (ELISA) plate. The NOS gene expression in the non-pregnant uterus, in an attempt absorbance of the supernatants was measured at 540 nm and was to better understand the mechanisms of non-pregnant myocorrected for the mean absorbance of a column of blank wells metrial activity. containing homogenization buffer. N-(1-naphthyl) ethylenediamine (NEDA) (Sigma) was added to each well at a final concentration of 1 mmol/l, and after a 10 min incubation at room temperature, absorbance readings at 540 nm were obtained for a second time. The
Materials and methods
assay was calibrated against a series of reference standard dilutions, Subjects each one containing sodium nitrite (NaNO 2 ) (BDH) and sodium nitrate (NaNO 3 ) (Sigma) (at concentrations of 0-10 µmol/l). All tissue samples were collected from women undergoing a gynaecoAbsorbance values before addition of NEDA were subtracted from logical operation at Women's Hospital, Walsgrave Hospitals' NHS the second absorbance readings. Trust, Coventry, UK. The study was approved by the local research ethics committee, and informed consent was obtained from each Immunoblotting patient prior to operation. Two groups of women participated in the study: (i) control group; 18 women (age 39-44 years), undergoing Snap-frozen endometrial and myometrial tissue was homogenized and cytosolic fractions were obtained as already described. For laparoscopy for sterilization and (ii) study group; 20 women (age 35-48 years) undergoing a hysterectomy for menorrhagia, under the detection of iNOS, sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out. 80 µg of cytosolic diagnosis of dysfunctional uterine bleeding. protein were diluted 1:1 v:v with electrophoresis SDS sample buffer glutamine, 10 000 IU/ml penicillin G (Sigma) and 7610 IU/ml streptomycin (Sigma), supplemented by one of the following: 5 µmol/ (125 mmol/l Tris-HCl, pH 6.8, 20% glycerol, 2% SDS, 0.003% Bromophenol Blue and 5% β-mercaptoethanol) (BDH) and l progesterone (Sigma); 5 µmol/l RU 486 (mifepristone) (kindly donated by Prof. E.-E.Baulieu, INSERM, Paris, France); 5 µmol/l were reduced by heating at 95°C for 5 min. Positive control aliquots (Transduction Labs, Lexington, KY, USA) of 5 µl mouse progesterone ϩ 10 µmol/l RU 486; 5 µM 17β-oestradiol (Sigma) ϩ 5 µmol/l progesterone; 5 µmol/l 17β-oestradiol. A 'no supplement' macrophage lysate samples, stimulated by interferon (IFN)-γ and LPS according to previous protocols (Xie et al., 1992) , were also loaded.
culture served as a negative control. Myometrial cells were plated into 25 cm 2 culture flasks (Nunc, Life Technologies, Paisley, UK), at After SDS-PAGE and electrophoretic transfer to a nitrocellulose membrane (Hybond-C; Pharmacia Amersham Life Science, Little a density of 0.5-2ϫ10 4 cells/cm 2 and stored at 37°C in humidified atmosphere (95% air and 5% CO 2 ) for 72 h. Chalfont, UK), non-specific sites were blocked overnight at 4°C, by 5% non-fat dry milk in Tris-buffered saline (TBS; 10 mmol/l Tris Cultured cells were identified as myometrial smooth muscle cells after performing immunocytochemistry using an anti-human smooth pH 7.5, 100 mmol/l NaCl) containing 0.01% Tween 20 (Sigma). Incubation with a mouse, anti-human iNOS antibody (Transduction muscle α-actin antibody (Gangula et al., 1997) . Myocyte monolayers, grown on 2-chamber glass slides (Falcon, Becton Dickinson, Oxford, Labs, 1:1000 dilution in TBS/Tween 20), raised against amino acids 961-1144 at the C-terminus of human iNOS, was carried out for 1 h UK), were fixed in acetone:methanol (50:50), for 5 min before incubation with an anti-human α-actin (Sigma), specific for smooth at room temperature. The blot was then washed in TBS (containing 0.01% Tween 20), four times for 5 min each. Incubation with the muscle cells (Roholl et al., 1990) . Cells were then stained with a fluorescent tetramethyl-rhodamine isothiocyanate (TRITC)-conjugsecondary antibody, a horseradish peroxidase conjugated goat antimouse immunoglobulin G (IgG, Sigma; 1:300 dilution in TBS/Tween ated IgG antibody (Sigma). Further staining with the DNA-specific dye 4,6-diamino-2-phenylindole (DAPI) (Sigma) allowed visualization of 20) followed for 45 min at room temperature. For detection of iNOS the membrane was subjected to enhanced chemiluminescence using the cell nuclei. the ECL detection reagents (Pharmacia Amersham) and then exposed Quantitative reverse-transcriptase polymerase chain to X-ray film (Kodak).
reaction (RT-PCR) Myocyte culture
Total ribonucleic acid (RNA) was extracted from myocyte monolayers originating from a menorrhagic patient, by solvent extraction using Myometrial biopsies, weighing~3 g were collected from women undergoing hysterectomy for menorrhagia. Primary myocyte cultures the ULTRASPEC reagent (Biotecx Laboratories, Houston, TX, USA), according to manufacturer's instructions. RNA was reverse transcribed were prepared as previously described (Phaneuf et al., 1993) . Smooth muscle myometrial tissue was incubated at 37°C, 5% CO 2 for 2 h into cDNA for use as the template for polymerase chain reaction (PCR) by using 2 µg total RNA samples and 5 IU/µl Maloney murine with gentle shaking/stirring, in HBSS containing 2.5 mmol/l CaCl 2 , 0.9 mmol/l MgCl 2 and 10 mg/ml (IU) dispase II (Roche Boehringer leukaemia virus (MMLV) RNase H reverse transcriptase (Superscript II) (Gibco BRL). Mannheim). The softened pieces of myometrium were washed in Ca 2ϩ /Mg 2ϩ -free HBSS (Gibco BRL, Life Technologies, Paisley, UK) PCR was carried out with specific primers (Gibco BRL) for human eNOS; 5Ј-CAG TGT CCA ACA TGC TGC TGG AAA TTG-3Ј and the cell dispersion was obtained in the same solution containing 300 IU/ml collagenase type 1A (Sigma), 2 IU/ml elastase (Sigma), (sense) and 5Ј-TAA AGG TCT TCT TCC TGG TGA TGC-3Ј (antisense), (Marsden et al., 1993; Weiner et al., 1994c) . Amplification 30 IU/ml DNase I type IV (Sigma) and 1 mg/ml fatty acid-free bovine serum albumin (FAF-BSA) (Sigma), after incubation at 37°C, for iNOS was carried out with primers 5Ј-GGA ATT CAC TCA GCT GTG CAT CG-3Ј (sense) and 5Ј-GTT TCC AGG CCC ATT CTC 5% CO 2 , for 2 h, as above. Tissue debris was removed by filtration through a 250 µm-diameter sterile sieve (Lockertex, Warrington, CTG C-3Ј (antisense) (Chartrain et al., 1994) , as described previously (Telfer et al., 1997) . For glyceraldehyde-3-phosphate dehydrogenase UK) and by washing three times with HBSS. Myocytes were resuspended in Dulbecco's modified Eagle's medium (DMEM) (GAPDH) the following pair of primers (Gibco BRL) was used; 5Ј-ACC ACA GTC CAT GCC ATC AC-3Ј (sense) and 5Ј-TCC ACC (Sigma), containing 10% fetal calf serum (Gibco BRL), 0.2% L-ACC CTG TTG CTG TA-3Ј (antisense), according to other workers (Ercolani et al., 1988) . 1 µl of the generated cDNA reaction was then used in the amplification reaction. PCR was performed in a 25 µl final volume using 10 µCi/µl [ 32 P]-labelled α-dGTP and 5 IU/µl Taq DNA polymerase (Gibco BRL).
Amplifications were carried out as follows: for eNOS, 35 cycles of 30 s at 94°C, 1 min at 58°C and 1 min at 72°C. For iNOS, an initial step at 94°C for 2 min, followed by 35 cycles of 1 min at 94°C, 1 min at 55°C, 1 min at 72°C and a final step of 1 cycle of Figure 2 . Immunoblotting for detection of endometrial and heating at 72°C for 10 min. Finally, for GAPDH, RT-PCR reactions myometrial inducible nitric oxide synthase (iNOS). The protein were performed as follows: one cycle of denaturing at 94°C for detected had a molecular size of 130 kDa in both endometrial and 4 min, 1 min at 60°C and 68°C extension for 1 min, followed by 28 myometrial tissue extracts, similar to the positive control mouse macrophage lysate. cycles of 30 s at 94°C, 30 s at 60°C and 2 min at 68°C. A final cycle of heating at 68°C for 5 min completed the amplification reaction for GAPDH. PCR products were added to 5 µl of denaturing stop solution (95% formamide, 20 mmol/l EDTA, 0.05% Bromophenol Blue, 0.05% menorrhagic endometrial biopsies collected were comparable xylene cyanol FF) (Pharmacia Amersham Life Sciences), denatured regarding stages of the menstrual cycle, we have not detected at 95°C for 5 min and separated by urea/acrylamide gel electrophoresis. any large differences of NOx amounts depending on particular
The dried gel was either exposed to a Kodak X-ray film or, specific stages of the menstrual cycle.
alternatively, to a phosphorimager screen (Molecular Dynamics, Pharmacia Amersham) for quantification purposes. Each product's metrium and myometrium, a low signal of protein expression
The identity of each of the PCR products and hence the specificity was obtained in both tissues, near the limit of clear detection.
of the PCR reaction were confirmed by DNA sequencing. 
Regulation of NOS gene expression by steroids in

Results
NOS regulation by steroids in myocyte primary cultures NOx assays
Quantitative RT-PCR was carried out to assess the effects of In order to test our hypothesis that overproduction of NO is steroids upon the amounts of eNOS and iNOS RNA in myocyte partly responsible for excessive menstrual bleeding, we measprimary cultures. ured NO indirectly by analysing the quantity of its oxidation products in uterine samples from normal and menorrhagic eNOS Using specific eNOS primers, a PCR product of 486 bp was endometrium. NOx amounts in menorrhagic endometrial samples (n ϭ 20) were higher than the corresponding controls obtained in all reactions performed (n ϭ 5). Nucleotide sequencing confirmed the product's identity as being human (n ϭ 18), as assessed by a Mann-Whitney U test. P Ͻ 0.01 was considered to be statistically significant (Figure 1b) . eNOS according to the known cDNA eNOS sequence. Addition of progesterone alone caused a 2.5-fold induction of eNOS The biopsies were randomly collected from women undergoing various phases of the menstrual cycle and the phase of RNA levels. 17β-oestradiol combined with progesterone caused a dramatic induction of~8-fold, whereas the 'antiprogeeach endometrial biopsy and corresponding median NOx values were recorded (Figure 1a) . However, while the control and stin' RU 486 caused a slight induction, and had little or no iNOS Using specific iNOS primers, the iNOS PCR product obtained had a size of 375 bp. Nucleotide sequencing results confirmed that the PCR product was corresponding to the expected iNOS nucleotide sequence. Steroid supplement had no effect on myocyte iNOS in vitro (Figures 4 and 6) , in contrast to the dramatic eNOS induction caused by 17β-oestradiol and progesterone. RU 486 treatment induced iNOS mRNA levels by~1.5-fold, while when combined with progesterone this increase was slightly inhibited.
Discussion
This study demonstrates for the first time differences in Norman et al., 1999) . In order to investigate our postulated role 1999). A lack of myocyte iNOS staining with occasional iNOS-expressing mast cells was previously shown . The function of these cells was considered to be immunological, since iNOS was more intensely expressed by pregnant myometrial cells, indicating a role of the specific isoform in uterine quiescence. In our attempt to determine specific NOS isoform regulation by progesterone and 17β-oestradiol we found a marked induction of eNOS by both steroid compounds in combination, while iNOS mRNA levels were unaffected. An induction caused by progesterone was postulated to participate in the events leading to excessive menstrual bleeding. We identified this steroid induction as a property of the Ca 2ϩ -dependent isoform eNOS and not as a characteristic of the menorrhagic tissue assessed. We have not been able to test if the same steroid effect applies to cases of non-menorrhagic tissue, since Although progesterone and 17β-oestradiol were found to sample (as in Figure 5 ). The NS ('no supplement') was set at 100. act synergistically, either progesterone or 17β-oestradiol had an effect on myometrial eNOS induction. Our observations on oestrogens agree with the other findings (Weiner et al., 1994a) of steroids in regulating uterine activity and NO production, we have also examined the induction of myometrial eNOS and where the constitutive NOS isoforms were shown to be induced by oestrogens, and with similar published work on animal iNOS RNA, the main myometrial NOS isoforms, by progesterone and 17β-oestradiol. models (Figueroa et al., 1995) . Oestrogens are known to induce vascular endothelial cell eNOS (Van Buren et al., 1992 ; NOx measurements in the form of NO 3 -and NO 2 -were carried out in order to monitor indirectly the total NOS activity Hayashi et al., 1995) , promoting blood flow. In contrast, it has been demonstrated that oestrogen does not induce Ca 2ϩ -in the menorrhagic and control endometrium. Increased NOx concentration was linked to menorrhagia, consistent with the dependent NOS in human endothelial and myometrial smooth muscle cells in vitro (Tschugguel et al., 1997) . The 'antiprogeshypothesis that uterine NO is implicated in excessive menstrual bleeding. While our study was not designed to investigate tin' RU 486 is expected to bind with high affinity to the progesterone receptor (Catepond et al., 1997) . Only a slight, changes in NOS activity with menstrual phase (as measured by NOx production), our data do not suggest an increase in partial inhibition of the progesterone effect on eNOS upregulation, has occurred in this case. iNOS does not seem to NOS activity during menstruation; we have not detected differences on NOx amounts between phases of the menstrual be regulated by progesterone and 17β-oestradiol in the case of the non-pregnant myometrium, although extensive work in cycle. According to previous work (Telfer et al., 1997) , no such differences were detected in NOS isoform expression, as pregnant rat models showed progesterone-mediated induction of iNOS, as the main isoform participating in maintenance of assessed by immunohistochemistry experiments. However, it has been suggested that endometrial Ca 2ϩ -independent NOS uterine quiescence (Buhimschi et al., 1995 (Buhimschi et al., , 1996 Liao et al., 1996; Ali et al., 1997) . We showed decrease in iNOS RNA activity is elevated during menstruation (Tschugguel et al., 1999) and this aspect merits further investigation. In menorrhalevels by 17β-oestradiol, in accordance with recent work suggesting inhibition of rat vascular smooth muscle iNOS by gia cases, excessive blood loss could have been a consequence of endometrial NO overproduction during the peri-menstrual 17β-oestradiol, via oestrogen receptor activation, indicating a novel mechanism for the protective steroid effects in cardiovasphase of the cycle and endometrially-derived NO could also play a role in the local control of myometrial contractility cular disease (Zancan et al., 1999) . Our current findings provide evidence on the importance of during menstruation.
NOS immunoreactivity was initially detected in the endometthe free radical gas NO in the aetiology of menorrhagia in the absence of organic disease. Endometrially-derived NO may rial glandular epithelium and stroma and in the myometrial blood vessels (Telfer et al., 1995) , suggesting a role for NO participate in the regulation of uterine blood flow as a vasodilator and may act on the neighbouring myometrial smooth in the paracrine control of the uterine vascular bed. eNOS and iNOS mRNA expression were later localized in isolated glands muscle cells, thus promoting uterine relaxation. The action of steroids is an additional event in myometrial relaxation, causing of non-pregnant endometrium and iNOS-like immunoreactivity was found in decidualized endometrial stromal cells and in further production of NO by stimulating eNOS expression. Therefore, it could be suggested that administration of NO first trimester pregnant tissue (Telfer et al., 1997) . Progestagen in-vivo treatment of women suffering from menorrhagia inhibitors could be an effective solution for menorrhagia patients and an alternative to surgical procedures such as showed no effect on NOS expression. Finally, eNOS and nNOS were present by immunoblotting and immunohistochemistry in endometrial ablation and hysterectomy. However, further work is necessary for better understanding of the molecular pregnant and non-pregnant myometrial tissue (Norman et al.,
